Chargement en cours...
Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
Monoclonal antibodies have revolutionized cancer therapy. However, delivery to tumor cells in vivo is hampered by the large size (150 kDa) of conventional antibodies. The minimal target recognition module of a conventional antibody is composed of two non-covalently associated variable domains (VH an...
Enregistré dans:
| Publié dans: | Front Immunol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5702627/ https://ncbi.nlm.nih.gov/pubmed/29213270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.01603 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|